Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

By LabMedica International staff writers
Posted on 24 Sep 2026

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. More...

Broader analysis from a single urine specimen could provide a more complete picture of potential exposure and help clinicians consider laboratory findings alongside symptoms and exposure history. A newly launched test expands urinary mycotoxin analysis to 31 markers and combines enhanced hydrolysis with liquid chromatography–tandem mass spectrometry to improve analytical detection.

The Mycotoxin Extensive Panel from RealTime Laboratories (Carrollton, TX, USA) is a urine-based assay that measures 31 clinical markers associated with potential mold exposure. In addition to mycotoxins such as satratoxins, roridins, and trichothecenes, the panel includes 16 newly added targets, including Chaetoglobosin A, Citrinin, and Fumonisins. Testing requires a single urine sample and is available through healthcare provider networks as well as direct-to-consumer channels; the panel is also HSA/FSA-eligible.

The assay uses liquid chromatography–tandem mass spectrometry (LC-MS/MS) together with a proprietary hydrolysis step designed to address metabolite modifications that can mask certain compounds in urine. By helping release these modified forms, the workflow may improve detection of mycotoxins that could be missed by standard approaches. The method is intended to provide a broader view of potential exposure from a single specimen and support interpretation alongside other clinical findings.

RealTime Laboratories is a CLIA-certified and CAP-accredited clinical laboratory. The new panel expands its range of integrative testing options, which also includes the All-Tox Profile and MOE-Tox Complete Profile. These tests assess mycotoxin exposure alongside environmental pollutants, heavy metals, and organic acids. The laboratory also offers an environmental mold and mycotoxin assessment (EMMA), which evaluates environmental samples for mold and for the same mycotoxins measured in urine by the Mycotoxin Extensive Panel.

“The expansion of our mycotoxin panel and methodologies underscores our commitment to diagnostic accuracy and rigorous laboratory standards. Serving as partners to both practitioners and patients, RealTime Labs empowers informed clinical action, improving confidence in treatment decision making,” said Jack Frausing, CEO of US BioTek, parent company of RealTime Labs.

“For practitioners, the value of comprehensive testing is having more information to consider as part of the overall clinical picture. By expanding the number of markers measured and using an expanded methodology designed to capture a wider range of mycotoxin metabolites, the panel builds on RealTime Labs' existing testing capabilities and provides additional context to support clinical decision-making,” said Marjorie Peak, ND, consulting physician for RealTime Labs.

Related Links
RealTime Labs


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.